sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
25-May-2016 16:49
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1001-1025 out of 1250.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>

Public Release: 3-Nov-2014
AAPS Annual Meeting and Exposition
Nasal spray vaccine has potential for long-lasting protection from Ebola virus
A nasal vaccine in development by researchers at the University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus.

Contact: Amanda Johnson
American Association of Pharmaceutical Scientists

Public Release: 3-Nov-2014
ASTMH 63rd Annual Meeting
Malaria from monkeys now dominant cause of human malaria hospitalizations in Malaysia
The majority of malaria hospitalizations in Malaysia are now caused by a dangerous and potentially deadly monkey-borne parasite once rarely seen in humans, and deforestation is the potential culprit in a growing number of infections that could allow this virulent malaria strain to jump from macaque monkeys to human hosts, according to research presented today at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting.

Contact: Preeti Singh

Public Release: 2-Nov-2014
ASTMH 63rd Annual Meeting
New malaria vaccines to prevent infection and block transmission get a shot in the arm
In support of a bold quest to rid the world entirely of malaria, the Bill & Melinda Gates Foundation today announced an award of US$156 million to PATH to support the PATH Malaria Vaccine Initiative in building new vaccines that will interrupt the cycle of malaria parasite transmission and help realize the 'accelerating to zero' agenda. Such vaccines would ensure that parasite reintroduction is prevented by providing what could be called an 'immunological bed net.'
Bill & Melinda Gates Foundation

Contact: Kelsey Mertes
PATH Malaria Vaccine Initiative (MVI)

Public Release: 2-Nov-2014
ASTMH 63rd Annual Meeting
New test will combat major cause of preventable blindness in Africa
PATH, an international nonprofit organization, announces the availability of a point-of care diagnostic tool for Onchocerciasis, commonly known as river blindness. It is the first in a suite of diagnostic innovations by PATH intended to support the elimination of neglected tropical diseases, a group of illnesses that affect more than a billion people worldwide.
The Bill & Melinda Gates Foundation

Contact: Kate Davidson

Public Release: 31-Oct-2014
New step towards eradication of H5N1 bird flu
A University of Adelaide-led project has developed a new test that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or 'bird flu' with those that have been naturally infected.

Contact: Dr. Farhid Hemmatzadeh
University of Adelaide

Public Release: 30-Oct-2014
Technology and Innovation
Patents for humanity: Special edition of Technology and Innovation
The current special issue of Technology and Innovation is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure. It includes original articles from winners of the 2013 USPTO Patents for Humanity Awards, aimed at rewarding innovators for deploying patented technologies to address humanitarian needs.

Contact: Diana Vergara
University of South Florida (USF Innovation)

Public Release: 30-Oct-2014
Hygienic funerals, better protection for health workers offer best chance to stop Ebola
Hygienic funeral practices, case isolation, contact tracing with quarantines, and better protection for health care workers are the keys to stopping the Ebola epidemic that continues to expand in West Africa, researchers said today in a new report in the journal Science. They said broad implementation of aggressive measures they recommend could lead to its control in Liberia, the focal point, by mid-March.
National Institutes of Health

Contact: Jan Medlock
Oregon State University

Public Release: 30-Oct-2014
Genetic factors behind surviving or dying from Ebola shown in mouse study
A newly developed mouse model suggests that genetic factors are behind the mild-to-deadly range of responses to the Ebola virus. The frequency of different manifestations of the disease across the lines of these mice are similar in variety and proportion to the spectrum of clinical disease observed in the 2014 West African outbreak. The new mouse model might be useful in testing candidate therapeutics and vaccines for Ebola, and in finding genetic markers for susceptibility and resistance to the disease.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases, Office of NIH Director

Contact: Leila Gray
University of Washington Health Sciences/UW Medicine

Public Release: 29-Oct-2014
Global Health Action
Largest ever dataset of individual deaths in Africa & SE Asia reveals changing health
An unprecedented insight into the changing health of people across Africa and Asia -- including the fluctuating burdens of HIV, malaria and childhood mortality -- is revealed today by the publication of the largest ever dataset of individual deaths recorded on-the-ground.
Bill & Melinda Gates Foundation, Doris Duke Charitable Foundation, IDRC, Rockefeller Foundation, Sida/Research Cooperation Unit, WHO/HMN, William & Flora Hewlett Foundation, Wellcome Trust

Contact: Clare Ryan
Wellcome Trust

Public Release: 29-Oct-2014
Global Public Health
NYU research: Tourism as a driver of illicit drug use, HIV risk in the DR
The study's results suggest three themes: 1, local demand shifts drug routes to tourism areas, 2, drugs shape local economies and 3, drug use facilitates HIV risk behaviors in tourism areas.
New York University/Global Public Health Research Challenge Fund

Contact: christopher james
New York University

Public Release: 29-Oct-2014
Maasai of Tanzania facing severe food insecurity and chronic child malnourishment
In the first in-depth study of its kind of the Maasai people of Tanzania, research led by the London School of Hygiene & Tropical Medicine has revealed that the health of Maasai children is very poor compared to other ethnic groups.
UK Medical Research Council

Contact: Jenny Orton
London School of Hygiene & Tropical Medicine

Public Release: 28-Oct-2014
Proceedings of the National Academy of Sciences
UC Davis scientists discover exact receptor for DEET that repels mosquitoes
The odorant receptor that makes DEET repellant to mosquitoes has been identified by a research team led by the University of California, Davis.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Pat Bailey
University of California - Davis

Public Release: 28-Oct-2014
ACP expresses concern about mandatory quarantines of clinicians involved
The American College of Physicians is strongly concerned about the approach being taken by some state health departments to impose strict, mandatory quarantines for all physicians, nurses, and other health professionals returning from West Africa, regardless of whether they are showing symptoms of Ebola virus infection.

Contact: David Kinsman
American College of Physicians

Public Release: 28-Oct-2014
PIDS supports IDSA statement on involuntary quarantine of healthcare workers returning from Ebola-affected countries
The Pediatric Infectious Diseases Society endorses a statement from the Infectious Diseases Society of America regarding involuntary quarantine of healthcare workers returning from Ebola-affected countries.

Contact: Terri Christene Phillips
Pediatric Infectious Diseases Society

Public Release: 28-Oct-2014
American Journal of Roentgenology
Lessons learned from SARS pandemic should inform current contagion protocols
Radiologists in Singapore outline the ways in which both medical facilities and practitioners there have incorporated lessons learned from the SARS pandemic.

Contact: Lissa D. Hurwitz
American Roentgen Ray Society

Public Release: 28-Oct-2014
11th International Conference of the Society for Integrative Oncology
UTHealth research shows mushroom extract, AHCC, helpful in treating HPV
A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus, according to a pilot clinical trial at The University of Texas Health Science Center at Houston Medical School.

Contact: Deborah Mann Lake
University of Texas Health Science Center at Houston

Public Release: 28-Oct-2014
Journal of the Royal Society Interface
Global infection outbreaks, unique diseases rising since 1980
Ebola has a lot of company. In a novel database now made publicly available, Brown University researchers found that since 1980 the world has seen an increasing number of infectious disease outbreaks from an increasing number of sources. The good news, however, is that they are affecting a shrinking proportion of the world population.
Brown University

Contact: David Orenstein
Brown University

Public Release: 27-Oct-2014
Annals of Internal Medicine
Study: Prompt isolation of symptomatic patients is key to eliminating Ebola
Below is information about an article being published in Annals of Internal Medicine. The information is not intended to substitute for the full article as a source of information. Annals of Internal Medicine attribution is required for all coverage.

Contact: Megan Hanks
American College of Physicians

Public Release: 27-Oct-2014
GW researcher adapting breakthrough technologies to combat parasitic worm infections
Paul Brindley, Ph.D., professor of microbiology, immunology, and tropical medicine, and scientific director of the Research Center for Neglected Diseases of Poverty at the George Washington University School of Medicine and Health Sciences, co-authored a perspective in the journal Science, calling for researchers to adapt new technologies to research neglected parasitic flatworms.

Contact: Lisa Anderson
George Washington University

Public Release: 27-Oct-2014
TWAS 25th General Meeting
Molecular biologist Muntaser Ibrahim wins C.N.R. Rao Prize
Every year, malaria kills about a million people worldwide, 90 percent of them in sub-Saharan Africa. Prize winner Muntaser Ibrahim studies the connection between malaria, human communities and genes.

Contact: Edward Lempinen

Public Release: 26-Oct-2014
Quarraisha Abdool Karim wins TWAS-Lenovo Prize
South African scientist named winner of The World Academy of Sciences' most prestigious award for commitment to life-saving research that protects African women from HIV/AIDS

Contact: Edward Lempinen

Public Release: 23-Oct-2014
University researchers to test whether Ebola survivors' blood can provide new treatment
The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in West Africa.
European Union

Contact: Sarah Stamper
University of Liverpool

Public Release: 23-Oct-2014
New England Journal of Medicine
Shorter TB treatment not a successful alternative
A clinical drug trial conducted in five Sub-Sahara African countries shows that a shortened (four month) treatment for tuberculosis is well tolerated and may work well in subsets of TB patients, but overall could not be considered as an alternative to the current six month standard treatment. The results of the study, a collaboration including researchers from the London School of Hygiene & Tropical Medicine, were published in the New England Journal of Medicine.
Special Programme for Research and Training in Tropical Diseases, European Commission

Contact: Jenny Orton
London School of Hygiene & Tropical Medicine

Public Release: 23-Oct-2014
PLOS Pathogens
A gut bacterium that attacks dengue and malaria pathogens and their mosquito vectors
Just like those of humans, insect guts are full of microbes, and the microbiota can influence the insect's ability to transmit diseases. A study published on Oct. 23 in PLOS Pathogens reports that a bacterium isolated from the gut of an Aedes mosquito can reduce infection of mosquitoes by malaria parasites and dengue virus. The bacterium can also directly inhibit these pathogens in the test tube, and shorten the life span of the mosquitoes that transmit both diseases.

Contact: George Dimopoulos

Public Release: 22-Oct-2014
NIH begins early human clinical trial of VSV Ebola vaccine
Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health's Clinical Center. Researchers at NIAID are conducting the early phase trial to evaluate the vaccine, called VSV-ZEBOV, for safety and its ability to generate an immune system response in healthy adults who are given two intramuscular doses, called a prime-boost strategy. The Walter Reed Army Institute of Research is simultaneously testing the vaccine candidate as a single dose at its Clinical Trials Center.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Kathy Stover
NIH/National Institute of Allergy and Infectious Diseases

Showing releases 1001-1025 out of 1250.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>